13F

Stock

Entrada Therapeutics, Inc.

TRDA · held by 6 managers

Reported value

$7M

Holders

6

+0 new · −0 exited

Holders’ est. mark

−$53.4K

Price effect on 2 books still in the name

Largest holder

$3.91M

CANTOR FITZGERALD, L. P.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
CANTOR FITZGERALD, L. P.67.3K$3.91MHeld
MORGAN STANLEY346.8K$2.01MHeld
BANK OF AMERICA CORP /DE/126.4K$733.4KHeld
BARCLAYS PLC60.6K$351.7K−$53.4KCut−$38.7K
Essential Partners LLC11$64−$5Added$30
IFP Advisors, Inc2$12Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.